ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 0464 • ACR Convergence 2021

    The Impact of Timely Post-Discharge Follow-up on Readmission Risk Among Patients with Systemic Lupus Erythematosus

    Maria Schletzbaum1, Nadia Sweet2, W Ryan Powell2, Andrea Gilmore Bykovskyi3, Farah Kaiksow2, Ann Sheehy2, Amy Kind2 and Christie Bartels2, 1University of Wisconsin School of Medicine and Public Health, Middleton, WI, 2University of Wisconsin School of Medicine and Public Health, Madison, WI, 3University of Wisconsin - Madison School of Nursing, Madison, WI

    Background/Purpose: Systemic lupus erythematosus (SLE) has the 6th highest hospital readmission rate of all US chronic diseases with significant health disparities and costs. Transitional care…
  • Abstract Number: 0610 • ACR Convergence 2021

    Evaluating Patient No Show Rates to Rheumatology Appointments Across a Regional Healthcare System

    Osman Bhatty1, Rebecca Schorr2, Tarun Sharma1 and Mary Chester Wasko1, 1Allegheny Health Network, Pittsburgh, PA, 2Highmark Health, Pittsburgh, PA

    Background/Purpose: No-show visits in various clinical settings are costly to providers and to health care systems, potentially representing between 3-14% of a clinic’s yearly income.…
  • Abstract Number: 1122 • ACR Convergence 2021

    Patient-perceived Solutions to the Treatment Barriers in Knee Osteoarthritis: A Qualitative Study from a Diverse Patient Group Including Racial/ethnic Minorities

    Jasvinder Singh, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Knee osteoarthritis (OA) has worse outcomes in racial/ethnic minorities. Yet, most of the qualitative studies include primarily Caucasian people with knee OA, with minimal…
  • Abstract Number: 0492 • ACR Convergence 2021

    Racial Differences in Glucocorticoid Use Among Medicaid Beneficiaries with Incident Systemic Lupus Erythematosus

    Mia Chandler1, Leah Santacroce2, Karen Costenbader3, Rishi Desai4, Seoyoung Kim2 and Candace Feldman2, 1Boston Children's Hospital, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Belmont, MA, 4Brigham and Women's Hospital/Harvard Medical School, Boston, MA

    Background/Purpose: Glucocorticoids (GCs) are an integral part of systemic lupus erythematosus (SLE) treatment. Long-term use of GCs is associated with adverse effects. This study evaluated…
  • Abstract Number: 0611 • ACR Convergence 2021

    Association of Area Deprivation Index and Practice Patterns of Medicare Part D Rheumatologists

    Shannon Tai1, Ikechukwu Mbonu2 and Michael Putman3, 1Medical College of Wisconsin, Milwaukee, WI, 2Medical College of Wisconsin, West Allis, WI, 3Medical College of Wisconsin, Brookfield, WI

    Background/Purpose: Geographic disparities in the distribution and practice patterns of rheumatology providers may negatively impact patients with rheumatic diseases. The objective of this study was…
  • Abstract Number: 1168 • ACR Convergence 2021

    Barriers to Effectiveness of Non-surgical Treatments for Knee Osteoarthritis in a Diverse Racial/Ethnic Population: A Nominal Group Qualitative Study

    Jasvinder Singh, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Knee osteoarthritis (OA) has worse outcome in racial/ethnic minorities, who also have more severe pain, disability and worse outcomes. However, most qualitative studies include…
  • Abstract Number: 0494 • ACR Convergence 2021

    The Distribution of Social Deprivation, Distance to Care and Disease Burden in Rheumatoid Arthritis Patients in the United States

    Sharon Dowell1, Huifeng Yun2, Jeffrey Curtis3, Lang Chen4, Manuela Pedra-Nobre5, Dianne Wollaston6, SAWSAN NAJMEY7, Cynthia Lawrence-Elliott8, Theresa Lawrence-Ford9, Heather North10, Robin Dore11, Soha Dolatabadi12, Thaila Ramanujam13, Anne Winkler14, Stacy Kennedy15, Stephanie Ott16, Stephanie Ledbetter17, Grace Wright18 and Gail Kerr19, 1Howard University College of Medicine, Washington, DC, 2University of Alabama Birmingham, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 4University of Alabama, Birmingham, AL, 5North Jersey Rheum. Center, Westfield, NJ, 6Memorial Advanced Rheumatology, Houston, TX, 7Midstate Rheumatology Center, PA, Freehold, NJ, 8North Georgia Rheum Group, Atlanta, GA, 9North Georgia Rheum Group, Atlanta, MD, 10Pardee UNC, Hendersonville, NC, 11Robin K. Dore, MD Inc, Tustin, CA, 12Soha Dolatabadi, MD, Los Angeles, CA, 13Santa Cruz Rheumatology, Inc., Santa Cruz, CA, 14Winkler Medical Practice, Springfield, MO, 15Rowan Diagnostic Clinic, Concord, NC, 16Fairfield Medical Center, Carroll, OH, 17University of Alabama at Birmingham, Birmingham, AL, 18Grace C Wright MD PC, and Association of Women in Rheumatology, New York, NY, 19Washington D.C., Veterans Affairs Medical Center (VAMC)/Georgetown and Howard Universities, Washington, DC

    Background/Purpose: The overall success of RA therapy is dependent on access to specialty care, insurance coverage and effective management of associated comorbidities. Whether RA disease…
  • Abstract Number: 0612 • ACR Convergence 2021

    Rheumatology Care for the Underserved in Central Texas

    Veena Patel, Rajvi Patel and Kevin Hackshaw, Dell Medical School - UT Health Austin, Austin, TX

    Background/Purpose: Health disparities exist among the uninsured and access to rheumatology is incredibly limited to this patient population. We reside in a state without Medicaid…
  • Abstract Number: 1178 • ACR Convergence 2021

    Implementation of a Dermatologic Manifestations of Connective Tissue Disease Learning Module Including All Skin Tones and Social Determinants of Health for Medical Students: A Pilot Study

    Mavra Masood, Fnu Nutan, Julia Nunley and Beth Rubinstein, Virginia Commonwealth University, Richmond, VA

    Background/Purpose: There is a dearth of resources for medical students on identifying skin findings of autoimmune disorders in skin of color. Considering how several rheumatologic…
  • Abstract Number: 0495 • ACR Convergence 2021

    Racial/Ethnic Differences in Multimorbidity Between Patients with Systemic Lupus Erythematosus and Comparators in a Large Nationwide US Study

    Ali Duarte-Garcia1, Herbert Heien1, Nilay Shah1 and Cynthia Crowson2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have an increased burden of multimorbidity. Racial/ethnic disparities have also been associated with an increased burden of multimorbidity.…
  • Abstract Number: 0613 • ACR Convergence 2021

    Racial/Ethnic Disparities in Prescription Medications in a Large Urban Medical Center

    J. Thomas Berry, William Galanter, Alia Welsh, Sandra Folarin, Reginald Woods and Huan Chang, UIC Medical Center, Chicago, IL

    Background/Purpose: African Americans and Hispanics with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) continue to have worse disease-related health outcomes relative to Whites. This…
  • Abstract Number: 1182 • ACR Convergence 2021

    Pilot Health Literacy Curriculum Addressing Skills and Content Knowledge for Adult and Pediatric Rheumatology Fellows

    Gabriel Tarshish1, Heather Archer-Dyer2, Pablo Joo3, Dawn Wahezi4, Tamara Tanner5, Rhonda Acholonu4, Tamar Rubinstein6 and Irene Blanco7, 1Children's Hospital at Montefiore, New York, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3UC Riverside School of Medicine, Riverside, CA, 4Children's Hospital at Montefiore, Bronx, NY, 5Montefiore Medical Center, Bronx, NY, 6Albert Einstein College of Medicine, White Plains, NY, 7Albert Einstein College of Medicine, Cresskill, NJ

    Background/Purpose: 36% of adults in the US have a basic to below basic level of health literacy. Studies show that limited health literacy (LHL) has…
  • Abstract Number: 0594 • ACR Convergence 2021

    The Burden of Systemic Lupus in Five Distinct Racial and Ethnic Groups in Israel: A Population-based Study

    Titilola Falasinnu1, Nada Rizk1, Becca Feldman2, Devy Zisman3, Michael Leshchinsky2, Gabriella Lawrence2, Yashaar Chaichian4 and Julia Simard1, 1Stanford School of Medicine, Stanford, CA, 2Clalit Research Institute, Clalit Health Services, Ramat Gan, Israel, 3Carmel Medical Center, Haifa, Israel, 4Stanford University, Los Gatos, CA

    Background/Purpose: Misclassification of race and ethnicity in data can impact how disparities in prevalence, incidence, severity, and complications of systemic lupus erythematosus (SLE) are interpreted.…
  • Abstract Number: 0614 • ACR Convergence 2021

    Sex and Race Based Utilization of Healthcare for Ocular Inflammation and Infection: Comparing the Results from the Medicare and the IRIS Data

    Krati Chauhan1 and James T. Rosenbaum2, 1Southern Illinois University - School of Medicine, Springfield, IL, 2Departments of Ophthalmology, Medicine, and Cell Biology, Oregon Health & Sciences University and Chair Emeritus, Legacy Devers Eye Institute, Portland, OR

    Background/Purpose: Health care utilization has an impact on disease progression and outcome in rheumatologic care. Disparities based on race, sex, education and income level affect…
  • Abstract Number: 1264 • ACR Convergence 2021

    Racial Differences in Chronic Glucocorticoid Use in Patients with SLE: A Cross Sectional Study

    James Sullivan1 and Emily Littlejohn2, 1Cleveland Clinic Lerner College of Medicine, Cleveland Heights, OH, 2Cleveland Clinic, Cleveland, OH

    Background/Purpose: Black patients with systemic lupus erythematosus (SLE) face higher rates of morbidity and mortality compared to White patients. Long-term glucocorticoid use has been associated…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology